|
SN-NJ-R028
N/A |
|
Quaternary ammonium chitosan composite hydrogel
|
¥Member visible
|
|
SN-NJ-R029
N/A |
|
Composite hydrogel containing mizoribine nanoparticles
|
¥Member visible
|
|
SN-NJ-R030
N/A |
|
Fluorouracil temperature sensitive in situ gel
|
¥Member visible
|
|
SN-NJ-R031
N/A |
|
Wound repair chitosan-based composite hydrogel
|
¥Member visible
|
|
SN-NJ-R032
N/A |
|
Composite hydrogel containing leflunomide nanoparticles
|
¥Member visible
|
|
SN-NJ-R033
N/A |
|
Composite hydrogel containing T cell stimulation nanoparticles
|
¥Member visible
|
|
SN-NJ-R034
N/A |
|
PLGA nanoparticle composite hydrogel containing activating immunity
|
¥Member visible
|
|
SN-NJ-R035
N/A |
|
Nucleic acid vaccine nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R036
N/A |
|
Antigen-containing nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R037
N/A |
|
Compound hydrogel containing immune-enhancing nanoparticles
|
¥Member visible
|
|
SN-NJ-R038
N/A |
|
Toxin-containing protein nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R039
N/A |
|
Composite hydrogel containing cyclosporin nanoparticles
|
¥Member visible
|
|
SN-NJ-R040
N/A |
|
Composite hydrogel containing cyclophosphamide nanoparticles
|
¥Member visible
|
|
SN-NJ-R041
N/A |
|
Composite hydrogel containing mizoribine nanoparticles
|
¥Member visible
|
|
SN-NJ-R042
N/A |
|
PLGA nanoparticle composite hydrogel containing rapamycin
|
¥Member visible
|
|
SN-NJ-R024
N/A |
|
DC cell immune enhancement adjuvant nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R025
N/A |
|
Temperature sensitive hydrogel
|
¥Member visible
|
|
SN-NJ-R026
N/A |
|
PLGA-PEG-PLGA warm water gel
|
¥Member visible
|
|
SN-NJ-R027
N/A |
|
Composite hydrogel containing methylprednisolone nanoparticles
|
¥Member visible
|
|
SN-NJ-R023
N/A |
|
PLCA-PEG temperature-sensitive hydrogel with OVA plasmid
|
¥Member visible
|
|
SN-NJ-R022
N/A |
|
PLCA-HA long-acting immune hydrogel
|
¥Member visible
|
|
SN-NJ-R021
N/A |
|
GM-CSF immunoenhancing hydrogel
|
¥Member visible
|
|
SN-NP-R50
N/A |
|
Nucleic acid vaccine vesicle compound hydrogel
|
¥Member visible
|
|
SN-NJ-R043
N/A |
|
Composite hydrogel containing tacrolimus nanoparticles
|
¥Member visible
|
|
SN-NJ-R044
N/A |
|
Composite hydrogel containing antibody-loaded nanoparticles
|
¥Member visible
|
|
SN-NJ-R045
N/A |
|
Biovaccine Nanoparticle Composite Hydrogel
|
¥Member visible
|
|
SN-NJ-R046
N/A |
|
Composite hydrogel containing adrenal cortex hormone nanoparticles
|
¥Member visible
|
|
SN-NJ-R047
N/A |
|
Containing glucocorticoid & hormone nanoparticle composite hydrogel
|
¥Member visible
|
|
SN-NJ-R048
N/A |
|
Composite hydrogel containing mycophenolate ester nanoparticles
|
¥Member visible
|
|
SN-NJ-R049
N/A |
|
PLGA nanoparticle composite hydrogel containing methotrexate
|
¥Member visible
|
|
SN-NJ-R050
N/A |
|
Composite hydrogel containing anti-lymphocyte globulin nanoparticles
|
¥Member visible
|
|
SN-NJ-R051
N/A |
|
Composite hydrogel containing PLGA vaccine nanoparticles
|
¥Member visible
|